ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer.

Endometrial cancer is the most common gynecologic and the fourth most common malignancy in women in the United States. Cross-sectional imaging plays a vital role in pretreatment assessment of endometrial cancers and should be viewed as a complementary tool for surgical evaluation and planning of these patients. Although transvaginal US remains the preferred examination for the screening purposes, MRI has emerged as the modality of choice for the staging of endometrial cancer and imaging assessment of recurrence or treatment response. A combination of dynamic contrast-enhanced and diffusion weighted MRI provides the highest accuracy for the staging. Both CT and MRI perform equivalently for assessing nodal involvement or distant metastasis. PET-CT is more appropriate for assessing lymphadenopathy in high-grade FDG-avid tumors or for clinically suspected recurrence after treatment. An appropriate use and guidelines of imaging techniques in diagnosis, staging, and detection of endometrial cancer and treatment of recurrent disease are reviewed.The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every two years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

[1]  E. Haacke,et al.  Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies , 2013, European Radiology.

[2]  M. Senda,et al.  Prognostic significance of SUVmax (maximum standardized uptake value) measured by [18F]FDG PET/CT in endometrial cancer , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Qingli Zhu,et al.  Imaging of Endometrial Carcinoma Using Contrast‐Enhanced Sonography , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[4]  W. Small,et al.  ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. , 2011, Ultrasound quarterly.

[5]  Yajun Li,et al.  The Value of the Apparent Diffusion Coefficient in Differentiating Stage IA Endometrial Carcinoma From Normal Endometrium and Benign Diseases of the Endometrium: Initial Study at 3-T Magnetic Resonance Scanner , 2010, Journal of computer assisted tomography.

[6]  S. Galimberti,et al.  Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T , 2010, European Radiology.

[7]  K. Matsuzaki,et al.  Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion , 2009, Acta radiologica.

[8]  T. Murakami,et al.  MR imaging of endometrial carcinoma for preoperative staging at 3.0 T: Comparison with imaging at 1.5 T , 2009, Journal of magnetic resonance imaging : JMRI.

[9]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[10]  S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[11]  M. Parmar,et al.  Lymphadenectomy in endometrial cancer – Authors' reply , 2009, The Lancet.

[12]  O. Kilickesmez,et al.  Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones , 2009, Acta radiologica.

[13]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[14]  E. Sala,et al.  Added Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Advanced Stage Disease in Patients With Endometrial Carcinoma , 2009, International Journal of Gynecologic Cancer.

[15]  F. Mazzariol,et al.  Efficacy of contrast-enhanced CT in assessing the endometrium. , 2008, AJR. American journal of roentgenology.

[16]  K. Sugimura,et al.  Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. , 2008, AJR. American journal of roentgenology.

[17]  T. Gungor,et al.  The evaluation of endometrial tumors by transvaginal and Doppler ultrasonography , 2008, Archives of Gynecology and Obstetrics.

[18]  G. Ferrandina,et al.  Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[19]  Andrea Mariani,et al.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. , 2008, Gynecologic oncology.

[20]  M. Bajka,et al.  [Measuring the death of invasion of endometrial carcinoma. Preoperative transvaginal ultrasound and correlation with intraoperative and histopathologic findings--a prospective study]. , 2008, Ultraschall in der Medizin.

[21]  K. Sugimura,et al.  Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer , 2008, Annals of nuclear medicine.

[22]  M. Yen,et al.  Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. , 2008, AJR. American journal of roentgenology.

[23]  G. Ligabue,et al.  3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. , 2008, AJR. American journal of roentgenology.

[24]  S. Fujii,et al.  Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results , 2008, European Radiology.

[25]  C. Tsampoulas,et al.  Local staging of endometrial carcinoma: role of multidetector CT , 2008, European Radiology.

[26]  D. Kim,et al.  Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients , 2007, International Journal of Gynecologic Cancer.

[27]  E. Miyagi,et al.  Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer , 2006, International Journal of Gynecologic Cancer.

[28]  E. Sala,et al.  [MRI of malignant neoplasms of the uterine corpus and cervix]. , 2007, Radiologia.

[29]  D. Levine,et al.  The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology , 2007, International Journal of Gynecologic Cancer.

[30]  A. Félix,et al.  Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and histopathologic evaluation , 2007, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[31]  S. Dobbs,et al.  The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. , 2006, Gynecologic oncology.

[32]  R. Reznek,et al.  Evaluation of endometrial carcinoma on magnetic resonance imaging , 2006, International Journal of Gynecologic Cancer.

[33]  G. Ambrosini,et al.  Risks and usefulness of sonohysterography in patients with endometrial carcinoma. , 2006, American journal of obstetrics and gynecology.

[34]  P. Grigsby,et al.  Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. , 2004, Gynecologic oncology.

[35]  G. Scambia,et al.  Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. , 2004, Radiology.

[36]  K. Togashi,et al.  Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer , 2003, Annals of nuclear medicine.

[37]  R. Hustinx,et al.  Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  I. Szabó,et al.  Assessment of myometrial and cervical invasion of endometrial cancer by transvaginal sonography. , 2001, European journal of gynaecological oncology.

[39]  S. Costantini,et al.  [The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma]. , 2001, La Radiologia medica.

[40]  D. Arko,et al.  High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[41]  A. Gadducci,et al.  An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. , 2000, Anticancer research.

[42]  R. Buller,et al.  Computed Tomography in Endometrial Carcinoma , 2000, Obstetrics and gynecology.

[43]  J. Alcázar,et al.  Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk , 2000, Acta obstetricia et gynecologica Scandinavica.

[44]  M. Segal,et al.  Radiologic staging in patients with endometrial cancer: a meta-analysis. , 1999, Radiology.

[45]  N. Sakuragi,et al.  A clinical and pathologic study on para‐aortic lymph node metastasis in endometrial carcinoma , 1997, Journal of surgical oncology.

[46]  K. Papadakis,et al.  Patterns of pulmonary metastasis from uterine cancer. , 1996, Oncology.

[47]  J. Brown,et al.  Local staging of endometrial carcinoma: comparison of transvaginal and intraoperative sonography and gross visual inspection. , 1996, AJR. American journal of roentgenology.

[48]  Y. Song,et al.  Detection of Deep Myometrial Invasion in Endometrial Carcinoma: Comparison of Trans vaginal Ultrasound, CT, and MRI , 1995, Journal of computer assisted tomography.

[49]  H. Kosuge,et al.  [The accuracy of computed tomography and magnetic resonance imaging in evaluating the extent of endometrial carcinoma]. , 1995, Nihon Sanka Fujinka Gakkai zasshi.

[50]  F. Kommoss,et al.  Transvaginal sonography of myometrial invasion depth in endometrial cancer , 1994, Acta obstetricia et gynecologica Scandinavica.

[51]  C. Belloni,et al.  Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. , 1993, AJR. American journal of roentgenology.

[52]  J. Shepherd Revised FIGO staging for gynaecological cancer , 1989, British journal of obstetrics and gynaecology.

[53]  J. Masselot,et al.  Lymphography in the initial evaluation of endometrial carcinoma , 1988, Gynecologic oncology.

[54]  L. Blumenson,et al.  Paraaortic Lymph Node Evaluation in Stage I Endometrial Carcinoma , 1982, Obstetrics and gynecology.

[55]  H. Salvesen,et al.  Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. , 2012, Clinical radiology.

[56]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[57]  P. Stentella,et al.  FIGO Stage I endometrial carcinoma: evaluation of lung metastases and follow-up. , 2008, European journal of gynaecological oncology.

[58]  R. Reznek,et al.  Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. , 2007, Clinical radiology.

[59]  Y. Yamashita,et al.  Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. , 1993, AJR. American journal of roentgenology.

[60]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.